ERBB2 and gastric cancer: T-DXd elicited substantial inhibitory effects on the proliferation of GC cell lines with low HER2 expression (AGS and SNU-484), as well as those with high HER2 expression (NCI-N87 and SNU-216) (Fig. 1A and B).